Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lessened its position in Avanos Medical, Inc. (NYSE:AVNS) by 3.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,577,635 shares of the company’s stock after selling 102,681 shares during the quarter. Dimensional Fund Advisors LP owned approximately 5.62% of Avanos Medical worth $51,346,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Tidal Investments LLC acquired a new position in shares of Avanos Medical during the 1st quarter worth about $439,000. BNP Paribas Financial Markets lifted its position in Avanos Medical by 314.4% during the 1st quarter. BNP Paribas Financial Markets now owns 53,583 shares of the company’s stock worth $1,067,000 after acquiring an additional 40,653 shares during the period. Norges Bank acquired a new stake in Avanos Medical during the 4th quarter worth approximately $7,016,000. Tributary Capital Management LLC lifted its position in Avanos Medical by 7.5% during the 1st quarter. Tributary Capital Management LLC now owns 742,455 shares of the company’s stock worth $14,782,000 after acquiring an additional 51,865 shares during the period. Finally, Boston Partners purchased a new position in shares of Avanos Medical during the 1st quarter worth approximately $571,000. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Avanos Medical Stock Performance

Shares of AVNS stock opened at $23.77 on Monday. Avanos Medical, Inc. has a 12-month low of $17.24 and a 12-month high of $25.36. The company has a market cap of $1.09 billion, a price-to-earnings ratio of -17.87 and a beta of 0.91. The stock has a 50 day simple moving average of $23.48 and a 200-day simple moving average of $20.99. The company has a current ratio of 2.28, a quick ratio of 1.49 and a debt-to-equity ratio of 0.13.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.05. The company had revenue of $171.70 million during the quarter, compared to the consensus estimate of $170.67 million. Avanos Medical had a return on equity of 4.48% and a net margin of 1.13%. Avanos Medical’s revenue was up 1.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.24 earnings per share. On average, equities analysts forecast that Avanos Medical, Inc. will post 1.39 EPS for the current year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.